A carregar...
The neuroprotective effect of latanoprost acts via klotho‐mediated suppression of calpain activation after optic nerve transection
Latanoprost was first developed for use in glaucoma therapy as an ocular hypotensive agent targeting the prostaglandin F2α (FP) receptor. Subsequently, latanoprost showed a neuroprotective effect, an additional pharmacological action. However, although it is well‐known that latanoprost exerts an ocu...
Na minha lista:
| Publicado no: | J Neurochem |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299490/ https://ncbi.nlm.nih.gov/pubmed/27859240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13902 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|